Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols

Skin Cancer


Abenavoli, L., Capasso, R., Milic, N., and Capasso, F. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010;24(10):1423–32.

ACS. American Cancer Society. 2013a. Cancer Facts and Figure 2013. Atlanta: American Cancer Society. Available at: Accessed 12/17/2013.

ACS. American Cancer Society. How is melanoma skin cancer diagnosed? Available at: Last updated 10/29/2013c. [Accessed December 4, 2013].

ACS. American Cancer Society. Lymph Nodes and Cancer. What is the lymph system? Available at: Last updated 3/6/2014b. Accessed 3/31/2014.

ACS. American Cancer Society. Skin Cancer: Basal and Squamous Cell. What are basal and squamous cell skin cancers? Available at: Last updated 2/20/2014a. Accessed 3/31/2014.

ACS. American Cancer Society. Skin Cancer: Basal and Squamous Cell. How are basal and squamous cell skin cancers staged? Available at: Last updated 2/2/2014c. Accessed 3/28/2014.

ACS. American Cancer Society. What should I look for? Available at: Last updated 1/25/2013b. [Accessed December 4, 2013].

Aguilera, P., Carrera, C., Puig-Butille, J. A.,  Benefits of oral Polypodium Leucotomos extract in MM high-risk patients. J Eur Acad Dermatol Venereol. 2013;27(9):1095–100.

Alam, M., and Ratner, D. Cutaneous squamous-cell carcinoma. N. Engl. J. Med. 2001;344(13):975–83.

Al-Arashi MY, Salomatina E, Yaroslavsky AN. Multimodal confocal microscopy for diagnosing nonmelanoma skin cancers. Lasers in surgery and medicine. Oct 2007;39(9):696-705.

Alcaraz, M., Achel, D. G., Olivares, A., Olmos, E., Alcaraz-Saura, M., and Castillo, J. Carnosol, radiation and melanoma: a translational possibility. Clin Transl Oncol. 2013;15(9):712–9.

Amin, S. H., Motamedi, K. K., Ochsner, M. C., Song, T. E., and Hybarger, C. P. Mechanisms and efficacy of vismodegib in the treatment of basal cell carcinoma. Discov Med. 2013;16(89):229–32.

Amini S, Viera MH, Valins W, Berman B. Nonsurgical innovations in the treatment of nonmelanoma skin cancer. The Journal of clinical and aesthetic dermatology. Jun 2010;3(6):20-34.

Asgari, M. M., Chren, M.-M., Warton, E. M., Friedman, G. D., and White, E. Supplement use and risk of cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol. 2011;65(6):1145–51.

Augustin, M., Bock, P. R., Hanisch, J., Karasmann, M., and Schneider, B. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung. 2005;55(1):38–49.

Badr, D., Kurban, M., and Abbas, O. Metformin in dermatology: an overview. J Eur Acad Dermatol Venereol. 2013;27(11):1329–35.

Bahner, J. D., and Bordeaux, J. S. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin. Dermatol. 2013;31(6):792–8.

Balch, C. M., Gershenwald, J. E., Soong, S. J.,  Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology. 2009;27(36):6199–206.

Barysch, M. J., Hofbauer, G. F., and Dummer, R. Vitamin D, ultraviolet exposure, and skin cancer in the elderly. Gerontology. 2010;56(4):410–3.

Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC. Human interferons alpha, beta and omega. Growth factors (Chur, Switzerland). Dec 2004;22(4):243-251.

Benjamin, C. L., Melnikova, V. O., and Ananthaswamy, H. N. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:265–82.

Berwick, M., and Erdei, E. O. Vitamin D and melanoma incidence and mortality. Pigment Cell Melanoma Res. 2013;26(1):9–15.

Bonina F. Effect of the supplementation with Red Orange Complex® on ultraviolet-induced skin damage in human volunteers. Bionap report. Santa Venerina, CT, Italy. 2008.

Bonina FP, Leotta C, Scalia G, Puglia C, Trombetta D, Tringali G, . . . Saija A. Evaluation of oxidative stress in diabetic patients after supplementation with a standardised red orange extract. Diabetes, nutrition & metabolism. Feb 2002;15(1):14-19.

Brightman, L., Warycha, M., Anolik, R., and Geronemus, R. Do lasers or topicals really work for nonmelanoma skin cancers? Semin Cutan Med Surg. 2011;30(1):14–25.

Buscemi S, Rosafio G, Arcoleo G, Mattina A, Canino B, Montana M, . . . Rini G. Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. The American journal of clinical nutrition. May 2012;95(5):1089-1095.

Caccialanza, M., Recalcati, S., and Piccinno, R. Oral polypodium leucotomos extract photoprotective activity in 57 patients with idiopathic photodermatoses. G Ital Dermatol Venereol. 2011;146(2):85–7.

Caltagirone, S., Rossi, C., Poggi, A., Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer. 2000;87(4):595–600.

Camouse MM, Domingo DS, Swain FR, Conrad EP, Matsui MS, Maes D, . . . Baron ED. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Experimental dermatology. Jun 2009;18(6):522-526.

Carillo J. Basal cell carcinoma. First Consult. Available at: Last updated 9/14/2012. Accessed 3/31/2014.

Carless, M. A., and Griffiths, L. R. Cytogenetics of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:227–40.

Carpenter RL, Lo HW. Hedgehog pathway and GLI1 isoforms in human cancer. Discovery medicine. Feb 2012;13(69):105-113.

Chaudhary, S. C., Kurundkar, D., Elmets, C. A., Kopelovich, L., and Athar, M. Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway. Photochem. Photobiol. 2012;88(5):1149–56.

Checkley, L. A., Rho, O., Angel, J. M. Metformin Inhibits Skin Tumor Promotion in Overweight and Obese Mice. Cancer Prevention Research (Phil). 2013. [Epub ahead of print]

Chen H, Tuck T, Ji X, Zhou X, Kelly G, Cuerrier A, Zhang J. Quality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol. Journal of agricultural and food chemistry. Jul 3 2013;61(26):6383-6392.

Chu MB, Fesler MJ, Armbrecht ES, Fosko SW, Hsueh E, Richart JM. High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases. Chemotherapy research and practice. 2013;2013:726925.

Covadonga Martínez González, M., Del Pozo, J., Paradela, S., Fernández Jorge, B., Fernández Torres, R., and Fonseca, E. Bowen's disease treated by carbon dioxide laser. A series of 44 patients. Journal of Dermatological Treatment. 2008;19(5):293–9.

Crinnion, W. Is modified citrus pectin an effective mobilizer of heavy metals in humans? Altern Med Rev. 2008;13(4):283–6.

Cukras, A. R. On the comparison of diagnosis and management of melanoma between dermatologists and MelaFind. JAMA Dermatol. 2013;149(5):622–3.

Cust AE, Goumas C, Vuong K, Davies JR, Barrett JH, Holland EA, . . . Jenkins MA. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study. BMC cancer. Sep 4 2013;13(1):406.

Davar, D., Tarhini, A. A., and Kirkwood, J. M. Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach. Clin. Dermatol. 2013;31(3):237–50.

Davies, A. M., Weinberg, U., and Palti, Y. Tumor treating fields: a new frontier in cancer therapy. Ann N Y Acad Sci. 2013;1291:86–95.

de Mejia, E. G., Ramirez-Mares, M. V., and Puangpraphant, S. Bioactive components of tea: cancer, inflammation and behavior. Brain Behav. Immun. 2009;23(6):721–31.

Demidov LV, Manziuk LV, Kharkevitch GY, Pirogova NA, Artamonova EV. Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up. Cancer biotherapy & radiopharmaceuticals. Aug 2008;23(4):477-482.

Desai T, Chen CL, Desai A, Kirby W. Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. Jan 2012;38(1):97-103.

Dhanalakshmi, S., Mallikarjuna, G. U., Singh, R. P., and Agarwal, R. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis. 2004;25(8):1459–65.

Dunki-Jacobs, E. M., Callender, G. G., and McMasters, K. M. Current management of melanoma. Curr Probl Surg. 2013;50(8):351–82.

Eisemann, N., Waldmann, A., Geller, A. C. Non-Melanoma Skin Cancer Incidence and Impact of Skin Cancer Screening on Incidence. 2013:1–8.

Ellis, L. Z., Liu, W., Luo, Y. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. Biochem Biophys Res Commun. 2011;414(3):551–6.

Erb, P., Ji, J., Kump, E., Mielgo, A., and Wernli, M. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:283–95.

Ernst, E., and Schmidt, K. Ukrain - a new cancer cure? A systematic review of randomised clinical trials. BMC Cancer. 2005;5:69.

Ernst, E., Schmidt, K., and Steuer-Vogt, M. K. Mistletoe for cancer? Int J Cancer. 2003;107(2):262–7.

Etzkorn, J. R., Parikh, R. P., Marzban, S. S. Identifying risk factors using a skin cancer screening program. Cancer Control. 2013;20(4):248–54.

Fartasch M, Diepgen TL, Schmitt J, Drexler H. The relationship between occupational sun exposure and non-melanoma skin cancer: clinical basics, epidemiology, occupational disease evaluation, and prevention. Deutsches Arzteblatt international. Oct 2012;109(43):715-720.

Fecher LA. Melanoma. First Consult. Available at: Last updated 8/22/2012. Accessed 3/31/2014.

Ferri FF. Squamous Cell Carcinoma. Ferri’s Clinical Advisor. Available at: 2014. Accessed 3/31/2014.

Ferris, L. K., and Harris, R. J. New diagnostic aids for melanoma. Dermatol Clin. 2012;30(3):535–45.

Firnhaber, J. M. Diagnosis and treatment of Basal cell and squamous cell carcinoma. Am Fam Physician. 2012;86(2):161–8.

Galiczynski, E. M., and Vidimos, A. T. Nonsurgical treatment of nonmelanoma skin cancer. Dermatol Clin. 2011;29(2):297–309–x.

Gamba, C. A., Swetter, S. M., Stefanick, M. L. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer. 2013;119(8):1562–9.

Gandini, S., Raimondi, S., Gnagnarella, P., Doré, J.-F., Maisonneuve, P., and Testori, A. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer. 2009;45(4):634–41.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer immunology, immunotherapy : CII. Oct 2006;55(10):1258-1266.

Gensler, H. L., Williams, T., Huang, A. C., and Jacobson, E. L. Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice. Nutr Cancer. 1999;34(1):36–41.

Ghaderi R, Sehatbakhsh S, Bakhshaee M, Sharifzadeh GR. Urinary melatonin levels and skin malignancy. Iranian journal of medical sciences. Jan 2014;39(1):64-67.

Glinsky, V. V., and Raz, A. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr. Res. 2009;344(14):1788–91.

Gloster HM, Jr., Brodland DG. The epidemiology of skin cancer. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. Mar 1996;22(3):217-226.

Guan H, Singh NP, Singh UP, Nagarkatti PS, Nagarkatti M. Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma. PloS one. 2012;7(4):e35650.

Guéniche, A., Benyacoub, J., Buetler, T. M., Smola, H., and Blum, S. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol. 2006;16(5):511–7.

Guillermo, R. F., Chilampalli, C., Zhang, X., Zeman, D., Fahmy, H., and Dwivedi, C. Time and dose-response effects of honokiol on UVB-induced skin cancer development. Drug Discov Ther. 2012;6(3):140–6.

Hamler, F., Hiesmayr, W., Korsh, O., and Melnyk, A. Ukrain monotherapy in malignant melanoma (case report). Drugs Exp Clin Res. 1996;22(3-5):235–7.

Hangai S, Iwase S, Kawaguchi T, Kogure Y, Miyaji T, Matsunaga T, . . . Yamaguchi T. Effect of active hexose-correlated compound in women receiving adjuvant chemotherapy for breast cancer: a retrospective study. Journal of alternative and complementary medicine (New York, N.Y.). Nov 2013;19(11):905-910.

Harwood, M., Wu, H., Tanabe, K., and Bercovitch, L. Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy. J. Am. Acad. Dermatol. 2005;53(3):474–7.

Heiduschka, G., Lill, C., Seemann, R. The effect of resveratrol in combination with irradiation and chemotherapy: Study using Merkel cell carcinoma cell lines. Strahlenther Onkol. 2014;190(1):75-80.

Hidvegi M, Tomoskozine RF, Lapis K, Raso E, Szende B. Immunostimulatory and metastasis inhibiting fermented vegetal material. Google Patents; 2002.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice. Toxicology and applied pharmacology. Jul 15 2007;222(2):152-158.

Horneber, M. A., Bueschel, G., Huber, R., Linde, K., and Rostock, M. Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008;(2):CD003297.

Huang, M. T., Ma, W., Yen, P. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis. 1997;18(1):83–8.

Huang, S.-C., Ho, C.-T., Lin-Shiau, S.-Y., and Lin, J.-K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem. Pharmacol. 2005;69(2):221–32.

Hughes-Davies TH. CDKN2A mutations in multiple primary melanomas. The New England journal of medicine. Jul 30 1998;339(5):347-348.

Hui, A. M., Jacobson, M., Markowitz, O., Brooks, N. A., and Siegel, D. M. Mohs micrographic surgery for the treatment of melanoma. Dermatol Clin. 2012;30(3):503–15.

Hulyalkar, R., Rakkhit, T., and Garcia-Zuazaga, J. The role of radiation therapy in the management of skin cancers. Dermatol Clin. 2011;29(2):287–96.

Inohara, H., and Raz, A. Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj. J. 1994;11(6):527–32.

Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, . . . Kondo K. Reduction of Adverse Effects by a Mushroom Product, Active Hexose Correlated Compound (AHCC) in Patients With Advanced Cancer During Chemotherapy-The Significance of the Levels of HHV-6 DNA in Saliva as a Surrogate Biomarker During Chemotherapy. Nutrition and cancer. Apr 2014;66(3):377-382.

Jansen, R., Wang, S. Q., Burnett, M., Osterwalder, U., and Lim, H. W. Photoprotection: Part I. Photoprotection by naturally occurring, physical, and systemic agents. J. Am. Acad. Dermatol. 2013;69(6):853.e1–853.e12.

Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. The Journal of clinical and aesthetic dermatology. Apr 2010;3(4):39-48.

Jensen, J. D., Wing, G. J., and Dellavalle, R. P. Nutrition and melanoma prevention. Clin. Dermatol. 2010;28(6):644–9.

Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sorensen HT. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study. Cancer. Oct 1 2012;118(19):4768-4776.

Johnson, D. B., and Sosman, J. A. Update on the targeted therapy of melanoma. Curr Treat Options Oncol. 2013;14(2):280–92.

Jones FI, Ramachandran S, Lear J, Smith A, Bowers B, Ollier WE, . . . Strange RC. The melanocyte stimulating hormone receptor polymorphism: association of the V92M and A294H alleles with basal cell carcinoma. Clinica chimica acta; international journal of clinical chemistry. Apr 1999;282(1-2):125-134.

Joosse, A., Koomen, E. R., Casparie, M. K., Herings, R. M. C., Guchelaar, H.-J., and Nijsten, T. Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J. Invest. Dermatol. 2009;129(11):2620–7.

Jou, P. C., Feldman, R. J., and Tomecki, K. J. UV protection and sunscreens: what to tell patients. Cleve Clin J Med. 2012;79(6):427–36.

Jung, M., Bu, S. Y., Tak, K.-H., Park, J.-E., and Kim, E. Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer. Nutr Res Pract. 2013;7(6):439–45.

Katiyar, S. K. Green tea prevents non-melanoma skin cancer by enhancing DNA repair. Arch. Biochem. Biophys. 2011;508(2):152–8.

Katiyar, S. K. Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. Int. J. Oncol. 2002;21(6):1213–22.

Katiyar, S. K., Korman, N. J., Mukhtar, H., and Agarwal, R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst. 1997;89(8):556–66.

Katiyar, S., Elmets, C. A., and Katiyar, S. K. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem. 2007;18(5):287–96.

Kaushik, G., Ramalingam, S., Subramaniam, D. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. Am. J. Surg. 2012;204(6):868–73.

Khalesi, M., Whiteman, D. C., Tran, B., Kimlin, M. G., Olsen, C. M., and Neale, R. E. A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiol. 2013;37(5):534–43.

Kim, R. H., and Armstrong, A. W. Nonmelanoma skin cancer. Dermatol Clin. 2012;30(1):125–39–ix.

Kimura, Y., and Sumiyoshi, M. French maritime pine bark (Pinus maritima Lam.) extract (Flavangenol) prevents chronic UVB radiation-induced skin damage and carcinogenesis in melanin-possessing hairless mice. Photochem. Photobiol. 2010;86(4):955–63.

Kudchadkar, R. R., Gonzalez, R., and Lewis, K. New targeted therapies in melanoma. Cancer Control. 2013;20(4):282–8.

Kurian, R. R., Di Palma, S., and Barrett, A. W. Basal Cell Carcinoma Metastatic to Parotid Gland. Head Neck Pathol. 2013. [Epub ahead of print]

Larson, B., Abeytunge, S., Seltzer, E., Rajadhyaksha, M., and Nehal, K. Detection of skin cancer margins in Mohs excisions with high-speed strip mosaicing confocal microscopy: a feasibility study. Br. J. Dermatol. 2013;169(4):922–6.

Latruffe N, Rifler JP. Bioactive polyphenols from grapes and wine emphasized with resveratrol. Current pharmaceutical design. 2013;19(34):6053-6063.

Lazareth, V. Management of non-melanoma skin cancer. Semin Oncol Nurs. 2013;29(3):182–94.

Lee KC, Weinstock MA. Melanoma is up: are we up to the challenge? J Invest Dermatol. 2009;129(7):1604-6.

Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Advances in experimental medicine and biology. 2008;624:89-103.

Lin JS, Eder M, Weinmann S, et al. Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 U.S. Preventive Services Task Force Recommendation [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Feb. (Evidence Syntheses, No. 82.) 1, Introduction. Available at:

Liu, L. S., and Colegio, O. R. Molecularly targeted therapies for melanoma. Int. J. Dermatol. 2013;52(5):523–30.

Lober CW, Larbig GG. Microcystic adnexal carcinoma (sclerosing sweat duct carcinoma). Southern medical journal. Feb 1994;87(2):259-262.

Lotze MT, Matory YL, Ettinghausen SE, Rayner AA, Sharrow SO, Seipp CA, . . . Rosenberg SA. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. Journal of immunology (Baltimore, Md. : 1950). Oct 1985;135(4):2865-2875.

Ma, C., and Armstrong, A. W. Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2. J Dermatolog Treat. 2014;25(5):401–8.

MacFarlane D. Skin Cancer Management: A Practical Approach. SpringerLink: Bücher. Springer, 2010.

Man'cheva, T. A., Demidov, D. V., Plotnikova, N. A., Kharitonova, T. V., Pashkevich, I. V., and Anisimov, V. N. Melatonin and metformin inhibit skin carcinogenesis and lipid peroxidation induced by benz(a)pyrene in female mice. Bull. Exp. Biol. Med. 2011;151(3):363–5.

Mannal, P. W., Schneider, J., Tangada, A., McDonald, D., and McFadden, D. W. Honokiol produces anti-neoplastic effects on melanoma cells in vitro. J Surg Oncol. 2011;104(3):260–4.

Marieb, E., and Hoehn, K. Human anatomy & physiology. 8 ed. 2009. San Francisco: Pearson Benjamin Cummings.

Martin GM, Stockfleth E. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. Journal of drugs in dermatology : JDD. May 2012;11(5):600-608.

Miller, A. J., and Mihm, M. C., Jr. Melanoma. N. Engl. J. Med. 2006;355(1):51–65.

Mueller T, Voigt W. Fermented wheat germ extract--nutritional supplement or anticancer drug? Nutrition journal. 2011;10:89.

NCI. National Cancer Institute. Cancer Staging Fact Sheet - National Cancer Institute. 2013; Available at: [Accessed November 1, 2013].

NCI. National Cancer Institute. Cancer Topical page. Cancer Drug Information. FDA Approval for Trametinib. Available at: 1/16/2014c. Accessed 3/31/2014.

NCI. National Cancer Institute. Melanoma Treatment (PDQ®). Stages of Melanoma. Available at: 2/7/2014b. Accessed 3/31/2014.

NCI. National Cancer Institute. SEER – Surveillance, Epidemiology, and End Results Program. SEER Stat Facts Sheet: Melanoma of the Skin. Available at: Accessed 3/28/2014a.

Ndiaye, M., Philippe, C., Mukhtar, H., and Ahmad, N. The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges. Arch. Biochem. Biophys. 2011;508(2):164–70.

Nguyen, T. H., and Ho, D. Q.-D. Nonmelanoma skin cancer. Curr Treat Options Oncol. 2002;3(3):193–203.

Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, . . . Parsons PG. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer research. Apr 15 2004;64(8):2833-2839.

Osmond, G. W., Augustine, C. K., Zipfel, P. A., Padussis, J., and Tyler, D. S. Enhancing melanoma treatment with resveratrol. J. Surg. Res. 2012;172(1):109–15.

Pacifico A, Leone G. Role of p53 and CDKN2A inactivation in human squamous cell carcinomas. Journal of biomedicine & biotechnology. 2007;2007(3):43418.

Paoli, J., Daryoni, S., Wennberg, A.-M. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm. Venereol. 2011;91(6):689–93.

Patil CA, Kirshnamoorthi H, Ellis DL, van Leeuwen TG, Mahadevan-Jansen A. A clinical instrument for combined raman spectroscopy-optical coherence tomography of skin cancers. Lasers in surgery and medicine. Feb 2011;43(2):143-151.

Pavlou, P., Rallis, M., Deliconstantinos, G., Papaioannou, G., and Grando, S. A. In-vivo data on the influence of tobacco smoke and UV light on murine skin. Toxicol Ind Health. 2009;25(4-5):231–9.

Payette, M. J., Whalen, J., and Grant-Kels, J. M. Nutrition and nonmelanoma skin cancers. Clin. Dermatol. 2010;28(6):650–62.

Pilkington, S. M., Massey, K. A., Bennett, S. P. Randomized controlled trial of oral omega-3 PUFA in solar-simulated radiation-induced suppression of human cutaneous immune responses. American Journal of Clinical Nutrition. 2013;97(3):646–52.

Platt, D., and Raz, A. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst. 1992;84(6):438–42.

Ponten F, Ren Z, Nister M, Westermark B, Ponten J. Epithelial-stromal interactions in basal cell cancer: the PDGF system. The Journal of investigative dermatology. Mar 1994;102(3):304-309.

Qin, X., Cui, Y., Shen, L. Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trials. Int J Cancer. 2013;133(5):1033–41.

Quigley, E. A., and Halpern, A. C. Microinvasive melanoma: cutaneous pharmacotherapeutic approaches. Am J Clin Dermatol. 2013;14(2):125–37.

Ramirez Boscá, A., Zapater, P., Betlloch, I. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial. Actas Dermosifiliogr. 2012;103(7):599–607.

Ramsay, J. R., Suhrbier, A., Aylward, J. H. The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers. Br. J. Dermatol. 2011;164(3):633–6.

Rao, B. K., and Ahn, C. S. Dermatoscopy for melanoma and pigmented lesions. Dermatol Clin. 2012;30(3):413–34.

Rass, K., and Reichrath, J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162–78.

Rehal, B., Merin, M. R., and Barr, K. Metastatic eccrine porocarcinoma. Cutis. 2013;92(2):67–70.

Roberts, W. E. Skin type classification systems old and new. Dermatol Clin. 2009;27(4):529–33–viii.

Robinson, J. K., and Dahiya, M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol. 2003;139(5):643.

Rogers, H. W., Weinstock, M. A., Harris, A. R. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283–7.

Rosen, C. J., Adams, J. S., Bikle, D. D. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr. Rev. 2012;33(3):456–92.

Rowe, D. E., Carroll, R. J., and Day, C. L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–28.

Rundhaug, J. E., Mikulec, C., Pavone, A., and Fischer, S. M. A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Mol Carcinog. 2007;46(8):692–8.

Rusciani, L., Proietti, I., Paradisi, A. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up. Melanoma Res. 2007;17(3):177–83.

Rusciani, L., Proietti, I., Rusciani, A. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J. Am. Acad. Dermatol. 2006;54(2):234–41.

Saija A, Tomaino A, Lo Cascio R, Rapisarda P, Dederen JC. In vitro antioxidant activity and in vivo photoprotective effect of a red orange extract. International journal of cosmetic science. Dec 1998;20(6):331-342.

Sak, K. Site-Specific Anticancer Effects of Dietary Flavonoid Quercetin. Nutr Cancer. 2014;66(2):177-93.

Sánchez, G., and Nova, J. Risk factors for squamous cell carcinoma, a study by the National Dermatology Centre of Colombia. Actas Dermosifiliogr. 2013;104(8):672–8.

Scheuer, C., Pommergaard, H.-C., Rosenberg, J., and Gögenur, I. Melatonin's protective effect against UV radiation: a systematic review of clinical and experimental studies. Photodermatol Photoimmunol Photomed. 2013. [Epub ahead of print]

Sebastien TS, Nelson BR, Lowe L, Baker S, Johnson TM. Microcystic adnexal carcinoma. Journal of the American Academy of Dermatology. Nov 1993;29(5 Pt 2):840-845.

Sharma, S. D., Meeran, S. M., and Katiyar, S. K. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-kappaB signaling in in vivo SKH-1 hairless mice. Mol. Cancer Ther. 2007;6(3):995–1005.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice. Journal of experimental therapeutics & oncology. 2009;8(1):43-51.

Shimizu, I., Cruz, A., Chang, K. H., and Dufresne, R. G. Treatment of squamous cell carcinoma in situ: a review. Dermatol Surg. 2011;37(10):1394–411.

Siegel, R., Naishadham, D., and Jemal, A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013;63(1):11–30.

Siller, G., Rosen, R., Freeman, M., Welburn, P., Katsamas, J., and Ogbourne, S. M. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. Australas. J. Dermatol. 2010;51(2):99–105.

Sime, S., and Reeve, V. E. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol. Photochem. Photobiol. 2004;79(2):193–8.

Singh, R., Akhtar, N., and Haqqi, T. M. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected]. Life Sci. 2010;86(25-26):907–18.

Skivka, L., Susak, Y., Trompak, O. The effect of monotherapy and combined therapy with NSC-631570 (Ukrain) on growth of low- and high-metastasizing B16 melanoma in mice. Journal of Oncology Pharmacy Practice. 2011;17(4):339–49.

Sonavane, K., Phillips, J., Ekshyyan, O. Topical curcumin-based cream is equivalent to dietary curcumin in a skin cancer model. J Skin Cancer. 2012;2012:147863.

Spierings EL, Fujii H, Sun B, Walshe T. A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. Journal of nutritional science and vitaminology. Dec 2007;53(6):536-539.

Stabuc, B., and Benedicic, D. Ukrain with chemotherapy in malignant melanoma (case report). Drugs Exp Clin Res. 1996;22(3-5):231–3.

Stoeckli, S. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngology - Head and Neck Surgery. 2001;125(3):221–6.

Stroud, M. L., Stilgoe, S., Stott, V. E., Alhabian, O., and Salman, K. Vitamin D-a review. Australian family physician. 2008;37(12):1002–5.

Sugimoto, S., Ishii, Y., Izawa, N. Photoprotective effects of Bifidobacterium breve supplementation against skin damage induced by ultraviolet irradiation in hairless mice. Photodermatol Photoimmunol Photomed. 2012;28(6):312–9.

Tarhini, A. A., Gogas, H., and Kirkwood, J. M. IFN-α in the treatment of melanoma. J Immunol. 2012;189(8):3789–93.

Thieu, K., Ruiz, M. E., and Owens, D. M. Cells of origin and tumor-initiating cells for nonmelanoma skin cancers. Cancer Lett. 2013;338(1):82–8.

Tsai, M.-L., Lai, C.-S., Chang, Y.-H., Chen, W.-J., Ho, C.-T., and Pan, M.-H. Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis. Food Funct. 2012;3(11):1185–94.

Usatine R, Scherer JE. Cutaneous squamous cell carcinoma. First Consult. Available at: Last updated 8/15/2011. Accessed 3/31/2014.

Uzarska M, Czajkowski R, Schwartz RA, Bajek A, Zegarska B, Drewa T. Chemoprevention of skin melanoma: facts and myths. Melanoma research. Dec 2013;23(6):426-433.

Vad, N. M., Yount, G., and Moridani, M. Y. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines. Melanoma Res. 2008;18(6):386–99.

Vaid, M., and Katiyar, S. K. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review). Int. J. Oncol. 2010;36(5):1053–60.

Vaid, M., Sharma, S. D., and Katiyar, S. K. Proanthocyanidins inhibit photocarcinogenesis through enhancement of DNA repair and xeroderma pigmentosum group A-dependent mechanism. Cancer Prevention Research. 2010;3(12):1621–9.

Vaid, M., Singh, T., Li, A. Proanthocyanidins inhibit UV-induced immunosuppression through IL-12-dependent stimulation of CD8+ effector T cells and inactivation of CD4+ T cells. Cancer Prevention Research. 2011;4(2):238–47.

Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, . . . Rees JL. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Human molecular genetics. Oct 1996;5(10):1663-1666.

van der Vliet HJ, Koon HB, Yue SC, Uzunparmak B, Seery V, Gavin MA, . . . Exley MA. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. Apr 1 2007;13(7):2100-2108.

van Ginkel, P. R., Darjatmoko, S. R., Sareen, D.,  Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest Ophthalmol Vis Sci. 2008;49(4):1299–306.

Warner, C. L., and Cockerell, C. J. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol. 2011;12(3):147–54.

Weide B, Derhovanessian E, Pflugfelder A, Eigentler TK, Radny P, Zelba H, . . . Garbe C. High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma. Cancer. Sep 1 2010;116(17):4139-4146.

Weill, F. S., Cela, E. M., Paz, M. L., Ferrari, A., Leoni, J., and González Maglio, D. H. Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis. Br J Nutr. 2012;:1–10.

Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ. 2005;331:481-4.

Wells, R., Gutkowicz-Krusin, D., Veledar, E., Toledano, A., and Chen, S. C. Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Arch Dermatol. 2012;148(9):1083–4.

Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC. Anatomic site, sun exposure, and risk of cutaneous melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Jul 1 2006;24(19):3172-3177.

Wikimedia Commons. File: Layers of the skin. Available at: Last updated 2/10/2013. Accessed 2/3/2014.

Wiley J. Perspectives in Dermatopathology. The ‘epidemic’ of melanoma between under- and overdiagnosis. J Cutan Pathol. 2012;39:9-16.

Wright CJ, McCormack PL. Trametinib: first global approval. Drugs. Jul 2013;73(11):1245-1254.

Yang, C. S., Wang, H., Li, G. X., Yang, Z., Guan, F., and Jin, H. Cancer prevention by tea: Evidence from laboratory studies. Pharmacol. Res. 2011;64(2):113–22.

Yao H, Ng SS, Huo LF, Chow BK, Shen Z, Yang M, . . . Lin MC. Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle. Molecular cancer therapeutics. Jun 2011;10(6):1082-1092.

Yiasemides, E., Sivapirabu, G., Halliday, G. M., Park, J., and Damian, D. L. Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis. 2009;30(1):101–5.

Yuan, X.-Y., Liu, W., Hao, J.-C., Gu, W.-J., and Zhao, Y.-S. Topical grape seed proanthocyandin extract reduces sunburn cells and mutant p53 positive epidermal cell formation, and prevents depletion of Langerhans cells in an acute sunburn model. Photomed Laser Surg. 2012;30(1):20–5.

Zattra, E., Coleman, C., Arad, S. Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice. Am. J. Pathol. 2009;175(5):1952–61.

Zhan H, Zheng H. The role of topical cyclo-oxygenase-2 inhibitors in skin cancer: treatment and prevention. American journal of clinical dermatology. 2007;8(4):195-200.